Auxiliary liver transplant is an ineffective treatment of primary hyperoxaluria

American Journal of Transplantation

Volumn 14, Issue 1, 2014, Pages 241-

  Trotter, J F ^a   Milliner, D ^b  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXALIC ACID;

GENETIC DISORDER; HUMAN; LETTER; LIVER CELL; LIVER TRANSPLANTATION; OXALOSIS 1; PRIORITY JOURNAL; TRANSPLANT SURGEON; URINARY EXCRETION;

EMBOLIZATION, THERAPEUTIC; HUMANS; HYPEROXALURIA, PRIMARY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; PORTAL VEIN;

EID: 84890917029     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12535     Document Type: Letter

References (4)

1. Elias N, Kawai T, Ko DSC, et al. Native portal vein embolization for persistent hyperoxaluria following kidney and auxiliary partial liver transplantation. Am J Transplant 2013; 10: 2739-2742.
2. Bergstralh EJ, Monico CG, Lieske JC, et al. Transplantation outcomes in primary hyperoxaluria. Am J Transplant 2010; 10: 2493-2501.
3. Danpure CJ., Primary hyperoxaluria. In:, Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 2001, pp. 3323-3367.
4. Guha C, Yamanouchi K, Jiang J, et al. Feasibility of hepatocyte transplantation-based therapies for primary hyperoxalurias. Am J Nephrol 2005; 25: 161-170.